Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,020 GBX | -0.55% |
|
-4.22% | +13.40% |
07-03 | ASTRAZENECA : Buy rating from Berenberg | ZD |
07-03 | Aptamer shares jump as inks agreement with AstraZeneca | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.40% | 238B | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B | |
-3.79% | 158B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Imfinzi, Lynparza Combination Recommended for Approval in Europe as Endometrial Cancer Treatment